🇺🇸 FDA
Patent

US 11690919

Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells

granted A61KA61K38/00A61K47/6817

Quick answer

US patent 11690919 (Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells) held by The Board of Regents of the University of Texas System expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61K47/6817, A61K47/6855, A61K47/6869